Cardiac adrenergic activity in experimental heart failure assessed with beta receptor blockade.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D006332:Cardiomegaly / Q000139:chemically induced; D002417:Cattle; D004837:Epinephrine / Q000097:blood; D006321:Heart / Q000503:physiopathology*; D006333:Heart Failure / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006452:Hemoglobinometry; D006863:Hydrogen-Ion Concentration; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D008722:Methods; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000097:blood; D009929:Organ Size; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*
D002245:Carbon Dioxide; D011433:Propranolol; D010100:Oxygen; D009638:Norepinephrine; D004837:Epinephrine